No association between cytochrome P450 and glutathione S-transferase gene polymorphism and risk of colorectal adenoma: Results from the UK flexible sigmoidoscopy screening trial

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 4, 2005, Pages 1028-1030

  Gunter, Marc J ^a   Watson, Mark A ^b   Loktionov, Alexandre S ^a   Mitrou, Panagiota ^a   Cecil, Tom ^c   Macklin, Christopher ^d   Cardwell, Christopher ^e   Bishop, D Timothy ^d   Primrose, John ^c   Atkin, Wendy S ^e   Bingham, Sheila A ^a,f  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^e ST MARK S HOSPITAL   (United Kingdom)

^f WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A1; CYTOCHROME P450 2E1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE M3; GLUTATHIONE TRANSFERASE T1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER RISK; CANCER SCREENING; COLORECTAL ADENOMA; CONTROLLED STUDY; DIETARY INTAKE; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SIGMOIDOSCOPY; SMOKING;

ADENOMA; COLORECTAL NEOPLASMS; CYTOCHROME P-450 ENZYME SYSTEM; DIET; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; GREAT BRITAIN; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; POLYMORPHISM, GENETIC; QUESTIONNAIRES; SIGMOIDOSCOPY; SMOKING;

EID: 20144387374     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-04-0740     Document Type: Article

References (12)

1. De Jong MM, Nolte IM, Meerman G, et al. Low-penetrance genes and their involvement in colorectal cancer susceptibility. Cancer Epidemiol Biomarkers Prev 2002;11:1332-52.
2. The UK Flexible Sigmoidoscopy Screening Trial Investigators. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a multicentre randomised trial. Lancet 2002;359:1291-300.
3. Loktionov A, Watson MA, Gunter M, Stebbings WSL, Speakman CTM, Bingham SA. Glutathione S-transferase gene polymorphisms in colorectal cancer patients: interaction between GSTM1 and GSTM3 allele variants as a risk modulating factor. Carcinogenesis 2001;22:1053-60.
4. Katoh T, Inatomi H, Nagaoka A, Sugita A. Cytochrome P4501A1 gene polymorphism and homozygous deletion of the glutathione S-transferase M1 gene in urothelial cancer patients. Carcinogenesis 1995;16:655-7.
5. Garte S, Gaspari L, Alexandrie AK, et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 2001;10:1239-48.
6. Inoue H, Kiyohara C, Marugame T, et al. Cigarette smoking, CYP1A1 MspI and GSTM1 genotypes, and colorectal adenomas. Cancer Res 2000;60:3749-52.
7. Sachse C, Smith G, Wilkie MJ, et al. Colorectal Cancer Study Group A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis 2002;23:1839-49.
8. Kiss I, Sandor J, Pajkos G, Bogner B, Hegedus G, Ember I. Colorectal cancer risk in relation to genetic polymorphism of cytochrome P450 1A1, 2E1, and glutathione-S-transferase M1 enzymes. Anticancer Res 2000;20:519-22.
9. Sivaraman L, Leatham MP, Yee J, Wilkens LR, Lau AF, Le Marchand L. CYP1A1 genetic polymorphisms and in situ colorectal cancer. Cancer Res 1994;54:3692-5.
10. Ishibe N, Stampfer M, Hunter DJ, Hennekens C, Kelsey KT. A prospective study of cytochrome P450 1A1 polymorphisms and colorectal cancer risk in men. Cancer Epidemiol Biomarkers Prev 2000;9:855-6.
11. Kawajiri K, Nakachi K, Imai K, Watanabe J, Hayashi S. The CYP1A1 gene and cancer susceptibility. Crit Rev Oncol Hematol 1993;14:77-87.
12. Slattery M, Samowitz W, Ma K, et al. CYP1A1, cigarette smoking and colon and rectal cancer. Am J Epidemiol 2004;160:842-52.